- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x SF4: IRON/SULFUR CLUSTER(Non-covalent)
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
FMN.5: 23 residues within 4Å:- Chain A: A.549, S.550, A.551, A.552, K.574, T.575, I.590, N.609, E.611, N.668, K.709, T.735, N.736, T.737, S.766, G.767, T.793, G.794, G.795, V.815, C.816, S.817, Q.820
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:A.552, A:I.590, A:N.609
- Hydrogen bonds: A:S.550, A:T.575, A:T.575, A:T.575, A:N.668, A:K.709, A:K.709, A:N.736, A:S.766, A:G.767, A:T.793, A:G.795, A:C.816, A:S.817
- Water bridges: A:S.550, A:N.609, A:G.794, A:G.794
FMN.11: 23 residues within 4Å:- Chain B: A.549, S.550, A.551, A.552, K.574, T.575, I.590, N.609, E.611, N.668, K.709, T.735, N.736, T.737, S.766, G.767, T.793, G.794, G.795, V.815, C.816, S.817, Q.820
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:A.551, B:A.552, B:I.590, B:N.609
- Hydrogen bonds: B:S.550, B:T.575, B:T.575, B:T.575, B:N.668, B:K.709, B:K.709, B:N.736, B:S.766, B:G.767, B:G.795, B:C.816, B:S.817
- Water bridges: B:S.550, B:N.609, B:G.794, B:G.794
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.6: 34 residues within 4Å:- Chain A: V.129, P.131, G.194, A.195, G.196, P.197, A.198, F.217, E.218, K.219, Q.220, G.225, L.226, E.230, I.231, R.235, K.259, S.260, L.261, G.282, I.283, G.284, P.286, L.310, D.342, T.343, D.346, V.447, G.480, D.481, N.487, T.488, T.489, S.492
28 PLIP interactions:28 interactions with chain A- Hydrophobic interactions: A:L.310, A:D.342, A:T.343
- Hydrogen bonds: A:V.129, A:A.195, A:A.198, A:K.219, A:G.225, A:L.226, A:R.235, A:R.235, A:L.261, A:L.261, A:D.342, A:D.481, A:N.487, A:T.489, A:T.489, A:S.492, A:S.492
- Water bridges: A:G.196, A:S.199, A:Y.222, A:G.284, A:L.285, A:L.285, A:T.488, A:V.490
FAD.12: 33 residues within 4Å:- Chain B: V.129, P.131, G.194, A.195, G.196, P.197, A.198, F.217, E.218, K.219, Q.220, G.225, L.226, E.230, I.231, R.235, K.259, S.260, L.261, G.282, I.283, G.284, L.310, D.342, T.343, D.346, V.447, G.480, D.481, N.487, T.488, T.489, S.492
28 PLIP interactions:28 interactions with chain B- Hydrophobic interactions: B:L.310, B:D.342
- Hydrogen bonds: B:V.129, B:A.195, B:A.195, B:A.198, B:K.219, B:G.225, B:L.226, B:R.235, B:R.235, B:L.261, B:L.261, B:D.342, B:D.481, B:N.487, B:T.489, B:T.489, B:S.492, B:S.492
- Water bridges: B:G.196, B:S.199, B:Y.222, B:G.284, B:L.285, B:L.285, B:T.488, B:V.490
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dobritzsch, D. et al., Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil. EMBO J. (2001)
- Release Date
- 2001-02-23
- Peptides
- DIHYDROPYRIMIDINE DEHYDROGENASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x SF4: IRON/SULFUR CLUSTER(Non-covalent)
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dobritzsch, D. et al., Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil. EMBO J. (2001)
- Release Date
- 2001-02-23
- Peptides
- DIHYDROPYRIMIDINE DEHYDROGENASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D